Regulatory

Higenamine is a beta-2 agonist added to the list of banned substances by the World Anti-Doping Agency (WADA) in 2017.

Dietary supplement industry leaders and consumer advocacy groups turned out in force at a hotly anticipated public meeting with FDA last week to discuss federal regulation of dietary supplements.

BLIS M18 is the second oral-health probiotic strain from Blis Technologies and its North American distributor Stratum Nutrition.

What can this rare sugar do that other alternative sweeteners can’t?

Parry Organic Spirulina from Parry Nutraceuticals has successfully passed the United States Pharmacopeia’s voluntary and rigorous Dietary Ingredient Verification Program 

Bioenergy Life Sciences received novel food authorization from the European Food Safety Authority for use of its D-ribose in fine bakery wares, milk drinks, and sports, isotonic, and energy drinks. 

ExcelVite has collaborated with USP and its Non-Botanical Dietary Supplements Expert Committee, to publish a new Plant Carotenes monograph. 

Amarin, maker of the omega-3 drug Vascepa, has failed in its attempt to get an investigation launched against several omega-3 dietary supplement products and suppliers.

FDA recently issued a new draft guidance stating that it intends to exercise enforcement discretion to allow the alternative sweetener allulose to be excluded from the total and added sugars declarations on the Nutritional Facts and Supplement Facts label. 

Through its ESM Technologies business, Stratum Nutrition received new joint pain and stiffness reduction, and cartilage protection claims with this recent Natural Product Number.

Graminex LLC has received Health Canada Approval under the Natura and Non-prescription Health Products Directorate for its PollenBerry Flower Pollen Extract.

FDA released its 2020 budget request last month, and one item in particular raised the eyebrows of industry members: a proposal for a mandatory dietary supplement product registry. But what does it mean long term?

Coinciding with this announcement, FDA also announced it has issued multiple warning letters to companies marketing CBD with unsubstantiated claims.

The American Herbal Products Association has adopted a new guidance policy for dietary supplements and food products containing hemp and hemp-derived cannabidiol. 

Are natural products still patentable? A federal circuit’s decision in a recent high-profile court case gives comfort to natural product marketers that they may indeed be able to, under the right circumstances, patent their natural products.

A lead toxicologist from Herbalife Nutrition discusses how her team conducted a study to measure the presence of hydroxyanthracene compounds in Aloe vera.

The Supplement Safety and Compliance Initiative (SSCI) released its new general and technical benchmarking guidance documents, and opened up a 30-day public comment period for the documents. 

Historically, when pharmaceutical and supplement brands pursue, promote, or sell products featuring the same, or similar, active ingredients, their relationship becomes antagonistic. But can things change?

Future brain health products must address not only mood and cognition, but also our taxed and increasingly attenuated attention spans.

Six individuals and two corporations based in Palm Beach County, FL, were indicted by the Department of Justice on March 7, 2019, for illegally marketing drugs, such as anabolic steroids, as dietary supplements. 

NSF to provide interim gap audits for GRMA standards while it awaits full accreditation. 

Norman “Ned” Sharpless, MD, has been appointed acting FDA commissioner following the announcement by current FDA commissioner Scott Gottlieb, MD, that he will resign his post shortly.

USDA released an updated regulatory timeline for industrial hemp, while FDA announced an upcoming meeting to discuss the fate of hemp CBD.

FDA Commissioner Scott Gottlieb is resigning from the agency, effective in a month.

When FDA Commissioner Scott Gottlieb, MD, announced in February that FDA intends to "strengthen" dietary supplement regulations, those I interviewed reacted with a sense of calm and-dare I say it-optimism.

How are contract manufacturers dealing with increased scrutiny and demands for traceability, transparency, and quality control?

FDA Commissioner Scott Gottlieb, MD, announced new efforts to reform FDA's oversight of dietary supplements. 

This year, ingredients and supplement categories at higher risk of adulteration include: selective androgen receptor modulators (SARMS), phenibut, tianeptine, higenamine, and certain high-profile botanical ingredients.